Evidence map›Paper›PMID 40226322›Full record

ArticleFrontiers in public health2025

Healthcare systems and health economics in GCC countries: informing decision-makers from the perspective of the Gulf health economics association.

Yazed AlRuthia, Sara Aldallal, Hana A Al-Abdulkarim, Ahmed Al-Jedai, Hajer Almudaiheem, Anas Hamad, Khalifa Elmusharaf, Mouza Saadi, Hamda Al Awar, Haleama Al Sabbah and 12 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Regional research priorities for medication safety and pharmacovigilance in gulf cooperation council countries: a modified Delphi consensus study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yazed AlRuthia *Pharmacoeconomics Research Unit, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Sara Aldallal *Dubai Health Authority, Dubai, United Arab Emirates.
Hana A Al-AbdulkarimDrug Policy and Economic Center, National Guard Health Affairs, Riyadh, Saudi Arabia.
Ahmed Al-JedaiTherapeutics Affairs, Ministry of Health, Riyadh, Saudi Arabia.
Hajer AlmudaiheemDepartment of Drug Policy and Regulation, Ministry of Health, Riyadh, Saudi Arabia.
Anas HamadDepartment of Pharmacy, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Khalifa ElmusharafPublic Health Programme at the University of Birmingham, Dubai, United Arab Emirates.
Mouza SaadiDepartment of Health Economics and Insurance Policies, Dubai Health Authority, Dubai, United Arab Emirates.
Hamda Al AwarDepartment of Health, Data Management and Healthcare Studies, Abu Dhabi, United Arab Emirates.
Haleama Al SabbahDepartment of Public Health Nutrition, Abu Dhabi University, Abu Dhabi, United Arab Emirates.
Suliman AlghnamSaudi Public Health Authority, Riyadh, Saudi Arabia.
Mohamed Al GhamdiGeneral Directorate of National Health Process and Economics, Saudi Health Council, Riyadh, Saudi Arabia.
Sarah S MonshiDepartment of Health Administration and Hospitals, College of Public Health and Health Informatics, Umm Al Qura University, Makkah, Saudi Arabia.
Nada AlAgilDepartment of Medical, Council of Cooperative Health Insurance, Riyadh, Saudi Arabia.
Mohamed Ebrahim Al KhalifaHealth Strategic Assessment Directorate, Supreme Council of Health, Manama, Bahrain.
Qasim AbdulkarimHealth Strategic Assessment Directorate, Supreme Council of Health, Manama, Bahrain.
Sawsan AbdulkarimFreelancer Management Consultant and Co-founder of the Bahrain Research Consortium, Manama, Bahrain.
Huda JawadDepartment of Pharmacy, University of Bahrain, Manama, Bahrain.
Sultana Al-SabahiMinistry of Health, Muscat, Oman.
Asiya Al KindiMinistry of Health, Muscat, Oman.
Said WaniMinistry of Health, Muscat, Oman.
Abdullah AlibrahimAssistant Professor, Industrial and Management Systems Engineering, Kuwait University, Kuwait, Kuwait.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the discovery of oil, citizens of the Cooperation Council for the Arab States of the Gulf (GCC), which includes Bahrain, Kuwait, Qatar, Oman, the United Arab Emirates, and Saudi Arabia, have enjoyed the benefits of universal healthcare. However, as the population and healthcare demands in the GCC continue to grow, financing these healthcare systems without adequately considering the value of reimbursed health technologies and the effectiveness of various policies has become increasingly challenging. While numerous narrative reviews and government reports have discussed the healthcare systems in these nations, they have not sufficiently addressed the approval processes, economic evaluations, and reimbursement mechanisms for health technologies. In response to this gap, experts in health economics and outcomes research (HEOR) from the Gulf Health Economics Association - recognized as key opinion leaders in public health and academia across the six GCC countries - conducted a focus group discussion. This focus group meeting, which was recorded and transcribed verbatim to be later thematically analyzed, aimed to characterize the current state of healthcare systems within the GCC, identify challenges in adopting and implementing health economic evaluations to inform policymakers and propose recommendations to expedite the integration of HEOR in the assessment of various health policies and technologies within their respective countries. The convened experts also underscored the importance of collaboration among GCC member states to enhance the adoption of robust health technology evaluations and improve patient access to cost-effective treatments.

Indexed as

Decision MakingDelivery of Health CareFocus GroupsHealth PolicyHumansMiddle EastGCC (Bahrain; Saudi Arabia; Kuwait; United Arab Emirates; Qatar; Oman; Arabian Gulf; Persian Gulf)healthcare efficiencyhealthcare financehealthcare systemhealth technology assesement (HTA)

Identifiers

PMID40226322
PMCPMC11986993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.